Celebi John 4
4 · Sensei Biotherapeutics, Inc. · Filed Dec 23, 2024
Insider Transaction Report
Form 4
Celebi John
DirectorPRESIDENT AND CEO
Transactions
- Award
Stock Option (Right to Buy)
2024-12-20+355,000→ 355,000 totalExercise: $0.45Exp: 2034-12-19→ Common Stock (355,000 underlying)
Footnotes (1)
- [F1]100% of the shares subject to the option shall vest on December 1, 2025, subject to the Reporting Person's continuous service with the Issuer as of such date.